Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A1C--frequently asked questions.

Patrick J Phillips1, George Phillipov

  • 1The Queen Elizabeth Hospital, Woodville, South Australia. patrick.phillips@hwahs.sa.gov.au

Australian Family Physician
|August 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal concentrations of Quaternary ammonium compounds in wastewater treatment effluents during the COVID-19 pandemic, 2020-2021.

Chemosphere·2024
Same author

Environmental and anthropogenic drivers of contaminants in agricultural watersheds with implications for land management.

The Science of the total environment·2021
Same author

Groundwater discharges as a source of phytoestrogens and other agriculturally derived contaminants to streams.

The Science of the total environment·2020
Same author

Pesticides and their degradates in groundwater reflect past use and current management strategies, Long Island, New York, USA.

The Science of the total environment·2020
Same author

Spatiotemporal variation in occurrence and co-occurrence of pesticides, hormones, and other organic contaminants in rivers in the Chesapeake Bay Watershed, United States.

The Science of the total environment·2020
Same author

Bacterial quality of groundwater downgradient of onsite wastewater disposal systems and the influence on eastern Long Island's embayments.

Marine pollution bulletin·2019
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Glycated haemoglobin (A1C) tests estimate average blood glucose over 6-8 weeks and are crucial for managing diabetes complications. Monitoring both A1C and daily blood glucose is vital for effective diabetes care.

Area of Science:

  • Endocrinology
  • Clinical Chemistry

Background:

  • Glycated haemoglobin (A1C) measurements, available since the 1970s, are the standard for assessing long-term glycaemic control.
  • A1C is recognized for estimating overall glycaemic exposure and predicting microvascular complication risk in diabetes.

Purpose of the Study:

  • To address common questions regarding A1C testing.
  • To provide practical guidance on optimizing the use of A1C measurements in clinical settings.

Main Methods:

  • Review of clinical guidelines and evidence.
  • Synthesis of information to answer frequently asked questions about A1C.

Main Results:

  • A1C provides a reliable 6-8 week average glycaemic exposure, complementing daily blood glucose monitoring.

Related Experiment Videos

  • Discrepancies between A1C and blood glucose can often be resolved by verifying testing methods.

    • Conclusions:

    • Both A1C and daily blood glucose monitoring are essential for comprehensive diabetes management.
    • Targeting an A1C below 7%, with a potential further 0.5% reduction, significantly lowers complication risks.
    • A strong correlation exists between A1C levels and the progression of microvascular complications in both type 1 and type 2 diabetes.